Caribou Biosciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Caribou Biosciences Inc
TickerCRBU
CIK #0001619856
CUSIP142038108
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address2929 7th Street, Suite 105, Berkeley, CA 94710
Source [EDGAR]
CIK Filing 2011 - 2025
[0001619856] 10-K
[0001619856] 10-Q
[0001619856] 3
[0001619856] 4
[0001619856] 5
[0001619856] 8-K
[0001619856] D
[0001619856] SC 13D
[0001619856] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Haurwitz Rachel E Caribou Biosciences Inc [2025-04-25] 0.0
Bank of America Corp /DE/ Caribou Biosciences Inc [2024-11-14] 5.6
Point72 Asset Management LP Caribou Biosciences Inc [2024-02-23] 4.5
Avidity Partners Management LP Caribou Biosciences Inc [2024-01-08] 7.2
Point72 Asset Management LP Caribou Biosciences Inc [2023-07-20] 4.5
Pfizer Inc Caribou Biosciences Inc [2023-07-10] 58.0
State Street Corp Caribou Biosciences Inc [2023-02-03] 5.24
BlackRock Inc Caribou Biosciences Inc [2023-02-03] 7.7
Dupont E I de Nemours & Co Caribou Biosciences Inc [2022-03-01] 5.24
Haurwitz Rachel E Caribou Biosciences Inc [2022-02-04] 5.5
PFM Health Sciences LP Caribou Biosciences Inc [2021-08-06] 7.2
Farallon Capital Partners LP Caribou Biosciences Inc [2021-08-03] 4.5
FMR LLC Caribou Biosciences Inc [2021-07-29] 0.0
Caribou Biosciences Inc Intellia Therapeutics Inc [2017-02-28] 0.0
Form 3/4/5 Filer 2011 - 2025
Haurwitz Rachel E.
Caribou Biosciences, Inc.
Guggenhime Andrew
Kanner Steven
Braunstein Scott
Kelly Timothy P
McClung Barbara G
Albertson Tina M.
Johnson David Lee
Sacks Natalie
Richardson-Heron Dara
Khan Ruhi Ahmad
Zheng Ran
Whiting Nancy
Ryali Sriram
Fischesser Ryan
O'Byrne Jason
Rizvi Syed Ali-aamir
FMR LLC
Long-McGie Jeffrey Stephen
Intellia Therapeutics, Inc.
Caribou Therapeutics Holdco, LLC
Form 13F Holdings
Firm Period DFND Voting Shares
Pfizer Inc [2025-06-30] SOLE 4,690,431 4,690,431
Vanguard Group Inc [2025-06-30] SOLE 0 4,060,765
Kynam Capital Management LP [2025-06-30] SOLE 3,067,774 3,067,774
Schonfeld Strategic Advisors LLC [2025-06-30] SOLE 2,272,866 2,272,866
BlackRock, Inc. [2025-06-30] SOLE 1,873,359 1,883,476
Millennium Management LLC [2025-06-30] SOLE 1,550,589 1,550,589
Two Sigma Advisers LP [2025-06-30] SOLE 1,389,400 1,447,800
PFM Health Sciences LP [2025-06-30] DFND 0 1,358,831
Dimensional Fund Advisors LP [2025-06-30] SOLE 1,059,809 1,152,771
Geode Capital Management LLC [2025-06-30] DFND 980,929 980,929
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 718,540 956,980
Two Sigma Investments LP [2025-06-30] SOLE 928,525 928,525
Aberdeen Group plc [2025-06-30] DFND 897,579 897,579
Bank of America Corp /DE/ [2025-06-30] DFND 0 808,900
Goldman Sachs Group Inc [2025-06-30] DFND 791,616 791,616
Pale Fire Capital SE [2025-06-30] DFND 0 775,055
FMR LLC [2025-06-30] DFND 716,521 729,441
Maverick Capital Ltd [2025-06-30] SOLE 652,542 652,542
AQR Capital Management LLC [2025-06-30] DFND 630,755 630,760
Royal Bank of Canada [2025-06-30] DFND 599,117 599,117
Cambridge Investment Research Advisors Inc [2025-06-30] SOLE 0 584,446
Renaissance Technologies LLC [2025-06-30] SOLE 532,121 532,121
Charles Schwab Investment Management Inc [2025-06-30] SOLE 529,449 529,449
Jane Street Group LLC [2025-06-30] DFND 483,610 483,610
72 Investment Holdings, LLC [2025-06-30] DFND 0 474,067
Green Alpha Advisors LLC [2025-06-30] SOLE 425,679 425,679
Milestone Asset Management LLC [2025-06-30] SOLE 0 409,562
State Street Corp [2025-06-30] DFND 358,163 358,163
&Partners [2025-06-30] SOLE 336,565 336,565
Morgan Stanley [2025-06-30] DFND 311,394 331,481
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com